VN August 2021
Vetnews | August 2021 25 Chronic kidney disease (CKD) has a very high prevalence in cats, with 33%of cats over the age of 12 years being affected 1 and is one of themost common medical reasons older cats are seen in veterinary practice 2 . In CKD, as kidney function deteriorates, the homeostatic mechanisms struggle to regulate fluid, electrolyte and mineral balances, and eventually clinical signs of uraemia occur 2 . Phosphorus is a mineral essential for life, with 86% of the body’s phosphorus retained in bones. It is also a constituent of cell membranes, DNA, RNA, and ATP (an essential part of energy systems). 3 Phosphate is freely filtered by the normal kidney but not actively secreted by the tubule, thus daily phosphate excretion from the body is highly dependent on the glomerular filtration rate (GFR). As the GFR decreases (such as in CKD), and if the dietary phosphorus intake remains the same, phosphorus will start to accumulate in the body. This rise in phosphate concentration in the body triggers an increased synthesis & secretion of parathyroid hormone (PTH). PTH reduces phosphate reabsorption in the tubule, thus increasing the amount of phosphate excreted in the urine. This adaptive response is initially helpful, as it helps maintain phosphate (and calcium) homeostasis. However, as CKD progresses and fewer functioning nephrons remain, secretion of PTH (driven by phosphate retention) becomes counterproductive and so mal-adaptive 2 , with chronic high levels of PTH leading to bone demineralisation (renal osteodystrophy). Additionally, phosphorus (and calcium) is deposited in the soft tissues, leading to mineralisation, which is thought to contribute to progressive renal injury (through nephrocalcinosis) and to the extra-renal (particularly cardiovascular) effects of secondary renal hyperparathyroidism (SRHP) 2,4 . Hyperphosphatemia in CKD is associated with decreased survival time in cats with naturally occurring CKD, and plasma phosphorus has been documented to be an independent predictor for progression of feline CKD 4 . There is evidence that feeding a phosphate restrictive veterinary renal failure diet reduces both plasma PTH and plasma phosphate concentration in cats with naturally occurring CKD (and thus reduces SRHP). In cats with CRF, plasma phosphate concentrations will vary due to a number of factors: dietary phosphate intake, circulating PTH concentrations, and the remaining ability of the kidney to excrete phosphate. It is thus apparent, from a clinical perspective, that the degree of phosphorus restriction required must be tailored to each individual cat 5 . This can be achieved by using a combination of diet (Royal Canin Early Renal vs Renal) and phosphate binders, with the degree of dietary phosphate restriction required to attain ideal post treatment plasma phosphate concentrations increasingwith the severity of kidney disease. 2 Classifying a feline patient diagnosed with CKD according to the IRIS staging system is useful to facilitate appropriate treatment and patient monitoring. Included are recommendations regarding control of plasma phosphate concentration according to the stage being treated, as can be seen in table 1. It must be noted, that while adverse effects of restricting phosphate are rare, it is recommended that plasma phosphate and calcium are measured routinely every 2 – 3 months in cats that have been stabilised on restricted phosphate diets 2 . This will assist in detecting potential hypophosphatemia, as well as hypercalcemia (which has been reported on occasion 6 ). The underlying cause of hypercalcemia in these cases is not understood, but it appears to result from phosphate restriction since feeding more phosphate in the diet leads to the plasma calcium ion concentration returning to within a normal range, and the plasma PTH concentration increasing into the measurable range. Since PTH is important for normal bone turnover, it is recommended to rather increase dietary phosphate levels than completely suppress PTH secretion. 2 This small proportion of cases further highlights the fact that different levels of phosphate restriction are needed in different cases, and that diet and treatment should be tailored according to the individual need of each cat with CKD. *References available on request Phosphorus and Feline CKD Dr Angeliki Kaldelis BSC, BVSC, RCVS Stage 1 (No azotaemia) Stage 2 (Mild azotaemia) Stage 3 (Moderate azotaemia) Stage 4 (Severe azotaemia) Post-treatment plasma P concentration <1.5 mmol/l <1.5 mmol/l <1.6 mmol/l <1.9 mmol/l
Made with FlippingBook
RkJQdWJsaXNoZXIy OTc5MDU=